Abstract

BackgroundLive, attenuated measles virus (MeV) vaccine strains were generated by adaptation to cell culture. The genetic basis for the attenuation of the vaccine strains is unknown. We previously reported that adaptation of a pathogenic, wild-type MeV to Vero cells or primary chicken embryo fibroblasts (CEFs) resulted in a loss of pathogenicity in rhesus macaques. The CEF-adapted virus (D-CEF) contained single amino acid changes in the C and matrix (M) proteins and two substitutions in the shared amino terminal domain of the phosphoprotein (P) and V protein. The Vero-adapted virus (D-VI) had a mutation in the cytoplasmic tail of the hemagglutinin (H) protein.ResultsIn vitro assays were used to test the functions of the wild-type and mutant proteins. The substitution in the C protein of D-CEF decreased its ability to inhibit mini-genome replication, while the wild-type and mutant M proteins inhibited replication to the same extent. The substitution in the cytoplasmic tail of the D-VI H protein resulted in reduced fusion in a quantitative fusion assay. Co-expression of M proteins with wild-type fusion and H proteins decreased fusion activity, but the mutation in the M protein of D-CEF did not affect this function. Both mutations in the P and V proteins of D-CEF reduced the ability of these proteins to inhibit type I and II interferon signaling.ConclusionAdaptation of a wild-type MeV to cell culture selected for genetic changes that caused measurable functional differences in viral proteins.

Highlights

  • Live, attenuated measles virus (MeV) vaccine strains were generated by adaptation to cell culture

  • Adaptation of a wild-type MeV to cell culture selected for genetic changes that caused measurable functional differences in viral proteins

  • Transient expression of wild-type and mutant proteins Adaptation of D87-wt to chicken embryo fibroblasts (CEFs) resulted in the introduction of four amino acid changes, V102A in the C protein, Y110H and V120A in the NTD of the P and V proteins, and T84I in the M protein

Read more

Summary

Introduction

Live, attenuated measles virus (MeV) vaccine strains were generated by adaptation to cell culture. The identification of genomic markers for the attenuation of MeV would facilitate surveillance of wild-type MeVs by providing a means to discriminate between wild-type viruses and vaccine strains of the same genotype. This genetic information could be used to monitor the safety and stability of new vaccine lots and could contribute to the development of improved vaccines for MeV. We have attempted to replicate the process of attenuation through cell culture adaptation with a wild-type MeV that is pathogenic for rhesus macaques [9,10]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call